The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)āCaremark Rx, Express Scripts (ESI), and OptumRxāand their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times